NDC 70518-4780-00 - OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4780
- Requested NDC
- 70518-4780-00
- Package NDCs from labels
- 70518-4780-0, 70518-4780-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 22N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb415b3-b1ba-42b8-e063-6394a90a90d7 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb42062-f298-5186-e063-6294a90ab043 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb44e1b-b24b-6c83-e063-6394a90a4b52 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb468db-3c38-922d-e063-6294a90adef8 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4b8ca-eced-b7ff-e063-6394a90aaefe | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 25W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb50784-444e-3bf3-e063-6294a90aa618 | 2026-10-25 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Umedica Laboratories USA Inc. | c49a7f23-2af0-4607-9f21-114970f8630d | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lifestar Pharma LLC | a337a621-bf57-4aa4-8224-4356fa2cdbc4 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | f20fd735-30c7-4f89-8ceb-b6186646eea6 | 2026-10-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| KARYNG Complete SPF Sunscreen Medium/Dark | SUNSCREEN | Karyng LLC | 335eee1e-ef1c-41da-e063-6294a90ac273 | 2026-10-20 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 1fff8245-2b65-4ab1-aaa2-6bbbc6ac5fe8 | 2026-10-19 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH 6M97XTV3HD |
| KARYNG Complete SPF Sunscreen Light/Medium | SUNSCREEN | Karyng LLC | 33596253-413d-fba3-e063-6394a90a39e4 | 2026-10-19 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5fc69fbf-c2d2-41ef-99bb-62a76ef74db2 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ALEX MD PHD Sheer Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | PHYSICIAN LABORATORIES INC | 8f64c4fa-92ee-4af0-ab1b-6c3673f9a622 | 2026-10-16 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.